Loading…
Chemoradiation in elderly patients with head and neck cancers: a single institution experience
Abstract Aims To evaluate the efficacy and toxicity of concurrent chemoradiation in patients with head and neck cancers aged 65 and older. Materials and methods Thirty-two elderly patients were treated with radical chemoradiation. Twenty-six (81.3%) out of thirty-two patients had stage III–IV diseas...
Saved in:
Published in: | American journal of otolaryngology 2015-03, Vol.36 (2), p.117-121 |
---|---|
Main Authors: | , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Abstract Aims To evaluate the efficacy and toxicity of concurrent chemoradiation in patients with head and neck cancers aged 65 and older. Materials and methods Thirty-two elderly patients were treated with radical chemoradiation. Twenty-six (81.3%) out of thirty-two patients had stage III–IV disease. Twenty-nine (90.6%) patients received concurrent weekly cisplatin or carboplatin, 3 (9.4%) patients received concurrent cetuximab or nimotuzumab. Total dose of radiotherapy ranged from 66 Gy to 70 Gy. Results Twenty-nine patients (90.6%) completed at least 5 cycles of concurrent chemotherapy. Twenty-four (77.6%) patients achieved complete response. Fourteen (45.2%) patients experienced grade 3 mucositis. None of our patients developed grade 3 or above hematological toxicity. Loco-regional control and overall survival at 2 year were 71.6% and 88.9%, respectively. Conclusions Chemoradiation in elderly patients with high precision radiotherapy is a feasible option. |
---|---|
ISSN: | 0196-0709 1532-818X |
DOI: | 10.1016/j.amjoto.2014.07.015 |